Close
Back to TAK Stock Lookup

Takeda (TAK) – Accesswire

Jan 31, 2024 04:05 PM Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset
May 31, 2022 03:40 AM Moderna and Takeda Announce Plans to Transfer Marketing Authorization for Spikevax(TM) COVID-19 Vaccine in Japan to Moderna
Mar 22, 2021 02:50 AM Evotec and Takeda Enter Strategic RNA Targeting Drug Discovery and Development Alliance

Back to TAK Stock Lookup